GB9903804D0 - Pluripotential cells-2 - Google Patents

Pluripotential cells-2

Info

Publication number
GB9903804D0
GB9903804D0 GBGB9903804.4A GB9903804A GB9903804D0 GB 9903804 D0 GB9903804 D0 GB 9903804D0 GB 9903804 A GB9903804 A GB 9903804A GB 9903804 D0 GB9903804 D0 GB 9903804D0
Authority
GB
United Kingdom
Prior art keywords
pluripotential cells
pluripotential
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9903804.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB9903804.4A priority Critical patent/GB9903804D0/en
Publication of GB9903804D0 publication Critical patent/GB9903804D0/en
Priority to PCT/GB2000/000576 priority patent/WO2000049137A2/en
Priority to EP00903886A priority patent/EP1153123A2/en
Priority to AU25636/00A priority patent/AU2563600A/en
Priority to JP2000599863A priority patent/JP2003514509A/en
Priority to CA002371900A priority patent/CA2371900A1/en
Priority to HK02102269.8A priority patent/HK1040741A1/en
Priority to HK02102672.9A priority patent/HK1042112A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/04—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from germ cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
GBGB9903804.4A 1999-02-20 1999-02-20 Pluripotential cells-2 Ceased GB9903804D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9903804.4A GB9903804D0 (en) 1999-02-20 1999-02-20 Pluripotential cells-2
PCT/GB2000/000576 WO2000049137A2 (en) 1999-02-20 2000-02-18 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell
EP00903886A EP1153123A2 (en) 1999-02-20 2000-02-18 Pluripotential cells-2
AU25636/00A AU2563600A (en) 1999-02-20 2000-02-18 Pluripotential cells-2
JP2000599863A JP2003514509A (en) 1999-02-20 2000-02-18 Pluripotent functional cells-2
CA002371900A CA2371900A1 (en) 1999-02-20 2000-02-18 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell
HK02102269.8A HK1040741A1 (en) 1999-02-20 2002-03-26 Pluripotential cells-2
HK02102672.9A HK1042112A1 (en) 1999-02-20 2002-04-10 Pluripotential cells-2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9903804.4A GB9903804D0 (en) 1999-02-20 1999-02-20 Pluripotential cells-2

Publications (1)

Publication Number Publication Date
GB9903804D0 true GB9903804D0 (en) 1999-04-14

Family

ID=10848084

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9903804.4A Ceased GB9903804D0 (en) 1999-02-20 1999-02-20 Pluripotential cells-2

Country Status (7)

Country Link
EP (1) EP1153123A2 (en)
JP (1) JP2003514509A (en)
AU (1) AU2563600A (en)
CA (1) CA2371900A1 (en)
GB (1) GB9903804D0 (en)
HK (2) HK1040741A1 (en)
WO (1) WO2000049137A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1368402A (en) * 2000-11-09 2002-05-21 Bresagen Ltd Cell reprogramming
AU2002330465B2 (en) * 2001-09-21 2006-07-27 Kyoto University Screening method for a reprogramming agent, reprogramming agent screened by the method, method for using the reprogramming agent, method for differentiating an undifferentiated fusion cell, and production method of cells, tissues and organs.
JP2004248505A (en) * 2001-09-21 2004-09-09 Norio Nakatsuji Undifferentiated fusion cell of somatic cell derived from es cell deficient in part or all of transplantation antigen and method for producing the same
CN103898047B (en) 2003-12-23 2020-03-03 维亚希特公司 Definitive endoderm
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
KR101455144B1 (en) 2006-01-31 2014-10-27 다이이찌 산쿄 가부시키가이샤 Method for purifying cardiac myocyte and presumptive cardiac myocyte derived from stem cell and fetus
US8293529B2 (en) 2006-04-28 2012-10-23 Daiichi Sankyo Company, Limited Method for inducing differentiation of pluripotent stem cells into cardiomyocytes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation

Also Published As

Publication number Publication date
WO2000049137B1 (en) 2001-05-17
AU2563600A (en) 2000-09-04
HK1042112A1 (en) 2002-08-02
EP1153123A2 (en) 2001-11-14
WO2000049137A3 (en) 2001-03-08
HK1040741A1 (en) 2002-06-21
JP2003514509A (en) 2003-04-22
WO2000049137A2 (en) 2000-08-24
CA2371900A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
DE60018571D1 (en) Hernienprothese
DE60008112D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE60008382D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE50008011D1 (en) Thixotropierungsmittel
DE60018288D1 (en) Polyphenylensulfidlegierungszusammensetzung
DE60027722D1 (en) Aspartyl-protease inhibitoren
DE50002614D1 (en) Sigma-delta-modulator
IL149622A0 (en) 4-pyridinyl-n-acyl-l-phenylalanines
DE60007505D1 (en) Propargyletherderivate
DE60011809D1 (en) Oxcarbazepinsuspension
DE50000137D1 (en) Spirofluorenopyrane
DE59909975D1 (en) Testleck
DE10081629D2 (en) Seilzugbefestigung
DE60012950D1 (en) Polyacetalharzzusammensetzung
DE50009469D1 (en) Common-rail-injektor
DE60001313D1 (en) Imidazodiazepinderivate
DE50010757D1 (en) Stilbenaufheller
GB9903804D0 (en) Pluripotential cells-2
DE50008218D1 (en) Common-rail-injektor
DE50012999D1 (en) Stirnwandisolation
DE60026282D1 (en) Photovervielfacherröhre
DE60004080D1 (en) Centroidintegration
DE60012212D1 (en) Orthotopisches totalkunstherz
AU141428S (en) Turnpiece

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)